Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients.
Christian Opherk, Nils Peters, Jürgen Herzog...
https://pubmed.ncbi.nlm.nih.gov/15364702/Actively Recruiting
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-08-31
100
Participants Needed
2
Research Sites
26 weeks
Total Duration
Researchers are studying CADASIL, a genetic condition affecting small blood vessels in the brain, by analyzing patients both retrospectively and prospectively. The goal is to understand how symptoms relate to genetic risks and specific brain imaging and biological markers. This study aims to classify patients by disease risk to help find personalized treatment targets. Participants with CADASIL will be observed over time without receiving experimental treatments, as this is an observational study. The research includes collecting genetic, clinical, biological, and neuroradiological data, focusing on the NOTCH3 gene mutation and deposits found in small vessels. The study tracks disease progression and risk factors for up to 30 months. During the study, participants will undergo assessments to deepen knowledge of their clinical and neuroradiological condition. Researchers will identify markers that may predict disease progression and examine how different mutations influence brain abnormalities. The main outcomes include improved understanding of CADASILs clinical features and potentially reversible risk factors, with follow-up lasting up to 30 months.
CONDITIONS
Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
A
Anna Bersano, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 months
Participants undergo regular assessments to collect clinical, genetic, biological, and brain imaging data to study disease progression.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Christian Opherk, Nils Peters, Jürgen Herzog...
https://pubmed.ncbi.nlm.nih.gov/15364702/Julie W Rutten, Bastian J Van Eijsden, Marco Duering...
https://pubmed.ncbi.nlm.nih.gov/30032161/Hugues Chabriat, Anne Joutel, Martin Dichgans...
https://pubmed.ncbi.nlm.nih.gov/19539236/M M Ruchoux, C A Maurage
https://pubmed.ncbi.nlm.nih.gov/9291937/Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Lead Sponsor